# OnCo record aranote (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/aranote/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "aranote", "NCT04736199" ;
  schema:name "ARANOTE"@en ;
  schema:description "ARANOTE showed that darolutamide added to hormone therapy alone, without chemotherapy, delayed the progression of newly metastatic prostate cancer on scans, extending the drug's use to men who cannot or do not want to have docetaxel."@en ;
  schema:url <https://onco.cc/trials/aranote/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04736199> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate-mhspc/>, <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/darolutamide/> ;
  onco:companies <https://onco.cc/companies/bayer/> ;
  onco:people <https://onco.cc/people/fred-saad/> .